Join Our Newsletter - Get important industry news and analysis sent to your inbox – sign up to our e-Newsletter here

GlobalData Epidemiologist Report: Global Covid cases pass 137 million – study looks at vaccine mix possibility

14 Apr 2021 (Last Updated April 14th, 2021 13:35)

14 April

Globally, the total confirmed cases of Covid-19 have reached over 137,464,000, with over 2,959,000 deaths and over 90,810,000 recoveries.

The US, India and Brazil occupy the first, second and third positions respectively, for total confirmed cases. India maintains its lead of more than 270,000 cases over Brazil.

Covid deaths surges in South American countries have been observed as Argentina, Colombia and Chile all displayed an increase in death rates per million population.

Chile recorded the highest death rate with over 1,790 deaths followed by Colombia and Argentina with 1,350 and 1,320 respectively.

A major study led by the University of Oxford, UK, is looking at whether Covid vaccines can be mixed for first and second doses.

The researchers announced the programme will be extended to include both Moderna and Novavax vaccines.

Chief investigator of the trial says the focus is to explore if multiple Covid vaccines that are available can be used more flexibly.

‘Mix-Matching’ will result in more people completing their Covid-19 immunisation course more rapidly as scientists continue to look for ways to accelerate mass vaccination.

Kamal Duran, MPH, Associate Epidemiologist at GlobalData Plc.